Ali J. Satvat is Director & 10% Owner at Eidos Therapeutics, Inc. (EIDX). They have made 4 open-market trades across 1 company since 2018, most recently 2026-06-22.
CIK 0001621788
4 open-market purchases totalling $171.2M since 2018, never a sale. Too few scored purchases to measure a record yet.
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.